96 related articles for article (PubMed ID: 12744883)
1. CpG-motifs enhance initial and sustained primary tetanus-specific antibody secreting cell responses in spleen and bone marrow, but are more effective in adult than in neonatal mice.
Pihlgren M; Tougne C; Schallert N; Bozzotti P; Lambert PH; Siegrist CA
Vaccine; 2003 Jun; 21(19-20):2492-9. PubMed ID: 12744883
[TBL] [Abstract][Full Text] [Related]
2. Delayed and deficient establishment of the long-term bone marrow plasma cell pool during early life.
Pihlgren M; Schallert N; Tougne C; Bozzotti P; Kovarik J; Fulurija A; Kosco-Vilbois M; Lambert PH; Siegrist CA
Eur J Immunol; 2001 Mar; 31(3):939-46. PubMed ID: 11241299
[TBL] [Abstract][Full Text] [Related]
3. Oligonucleotide containing CpG motifs enhances immune response to mucosally or systemically administered tetanus toxoid.
Eastcott JW; Holmberg CJ; Dewhirst FE; Esch TR; Smith DJ; Taubman MA
Vaccine; 2001 Feb; 19(13-14):1636-42. PubMed ID: 11166886
[TBL] [Abstract][Full Text] [Related]
4. Unresponsiveness to lymphoid-mediated signals at the neonatal follicular dendritic cell precursor level contributes to delayed germinal center induction and limitations of neonatal antibody responses to T-dependent antigens.
Pihlgren M; Tougne C; Bozzotti P; Fulurija A; Duchosal MA; Lambert PH; Siegrist CA
J Immunol; 2003 Mar; 170(6):2824-32. PubMed ID: 12626532
[TBL] [Abstract][Full Text] [Related]
5. Nasal immunization studies using liposomes loaded with tetanus toxoid and CpG-ODN.
Tafaghodi M; Jaafari MR; Sajadi Tabassi SA
Eur J Pharm Biopharm; 2006 Oct; 64(2):138-45. PubMed ID: 16797952
[TBL] [Abstract][Full Text] [Related]
6. Generation of adult-like antibody avidity profiles after early-life immunization with protein vaccines.
Schallert N; Pihlgren M; Kovarik J; Roduit C; Tougne C; Bozzotti P; Del Giudice G; Siegrist CA; Lambert PH
Eur J Immunol; 2002 Mar; 32(3):752-60. PubMed ID: 11870619
[TBL] [Abstract][Full Text] [Related]
7. Adjuvants Enhance the Induction of Germinal Center and Antibody Secreting Cells in Spleen and Their Persistence in Bone Marrow of Neonatal Mice.
Aradottir Pind AA; Dubik M; Thorsdottir S; Meinke A; Harandi AM; Holmgren J; Del Giudice G; Jonsdottir I; Bjarnarson SP
Front Immunol; 2019; 10():2214. PubMed ID: 31616417
[TBL] [Abstract][Full Text] [Related]
8. Adjuvant effects of CpG oligodeoxynucleotides on responses against T-independent type 2 antigens.
Kovarik J; Bozzotti P; Tougne C; Davis HL; Lambert PH; Krieg AM; Siegrist CA
Immunology; 2001 Jan; 102(1):67-76. PubMed ID: 11168639
[TBL] [Abstract][Full Text] [Related]
9. Induction of systemic and mucosal immune responses by intranasal administration of alginate microspheres encapsulated with tetanus toxoid and CpG-ODN.
Tafaghodi M; Sajadi Tabassi SA; Jaafari MR
Int J Pharm; 2006 Aug; 319(1-2):37-43. PubMed ID: 16701972
[TBL] [Abstract][Full Text] [Related]
10. The adjuvant LT-K63 can restore delayed maturation of follicular dendritic cells and poor persistence of both protein- and polysaccharide-specific antibody-secreting cells in neonatal mice.
Bjarnarson SP; Adarna BC; Benonisson H; Del Giudice G; Jonsdottir I
J Immunol; 2012 Aug; 189(3):1265-73. PubMed ID: 22753937
[TBL] [Abstract][Full Text] [Related]
11. Long-term antibody production is sustained by antibody-secreting cells in the bone marrow following acute viral infection.
Slifka MK; Ahmed R
Ann N Y Acad Sci; 1996 Oct; 797():166-76. PubMed ID: 8993360
[TBL] [Abstract][Full Text] [Related]
12. Oral, intrarectal and intranasal immunizations using CpG and non-CpG oligodeoxynucleotides as adjuvants.
McCluskie MJ; Davis HL
Vaccine; 2000 Oct; 19(4-5):413-22. PubMed ID: 11027803
[TBL] [Abstract][Full Text] [Related]
13. Effects of skeletal unloading on the bone marrow antibody repertoire of tetanus toxoid and/or CpG treated C57BL/6J mice.
Rettig TA; Nishiyama NC; Pecaut MJ; Chapes SK
Life Sci Space Res (Amst); 2019 Aug; 22():16-28. PubMed ID: 31421845
[TBL] [Abstract][Full Text] [Related]
14. IgG anti-tetanus toxoid antibody synthesis by human bone marrow. I. Two distinct populations of marrow B cells and functional differences between marrow and peripheral blood B cells.
Lum LG; Burns E; Janson MM; Martin PJ; Giddings BR; Seigneuret MC; Noges JE; Galoforo SC
J Clin Immunol; 1990 Sep; 10(5):255-64. PubMed ID: 2176226
[TBL] [Abstract][Full Text] [Related]
15. Antigen-specific B and T cells in human/mouse radiation chimera following immunization in vivo.
Böcher WO; Marcus H; Shakarchy R; Dekel B; Shouval D; Galun E; Reisner Y
Immunology; 1999 Apr; 96(4):634-41. PubMed ID: 10233752
[TBL] [Abstract][Full Text] [Related]
16. IC31, a two-component novel adjuvant mixed with a conjugate vaccine enhances protective immunity against pneumococcal disease in neonatal mice.
Olafsdottir TA; Lingnau K; Nagy E; Jonsdottir I
Scand J Immunol; 2009 Mar; 69(3):194-202. PubMed ID: 19281531
[TBL] [Abstract][Full Text] [Related]
17. The potential of oligodeoxynucleotides as mucosal and parenteral adjuvants.
McCluskie MJ; Weeratna RD; Davis HL
Vaccine; 2001 Mar; 19(17-19):2657-60. PubMed ID: 11257405
[TBL] [Abstract][Full Text] [Related]
18. CpG DNA is an effective oral adjuvant to protein antigens in mice.
McCluskie MJ; Weeratna RD; Krieg AM; Davis HL
Vaccine; 2000 Nov; 19(7-8):950-7. PubMed ID: 11115721
[TBL] [Abstract][Full Text] [Related]
19. Novel immunostimulatory phosphodiester oligodeoxynucleotides with CpT sequences instead of CpG motifs.
Kim D; Jung J; Lee Y; Kwon HJ
Mol Immunol; 2011 Jul; 48(12-13):1494-504. PubMed ID: 21529949
[TBL] [Abstract][Full Text] [Related]
20. Immunization of aged mice with a pneumococcal conjugate vaccine combined with an unmethylated CpG-containing oligodeoxynucleotide restores defective immunoglobulin G antipolysaccharide responses and specific CD4+-T-cell priming to young adult levels.
Sen G; Chen Q; Snapper CM
Infect Immun; 2006 Apr; 74(4):2177-86. PubMed ID: 16552048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
